Dilated Cardiomyopathy (DCM) is a critical cardiovascular condition marked by the enlargement of the heart's chambers, particularly the left ventricle. This pathology results in the weakening of the heart muscle, compromising its ability to pump blood effectively. The dilation and diminished pumping function characterize the heart's struggle in maintaining its normal operation. Various factors contribute to the development of DCM, such as genetic predisposition, viral infections, certain medications, and exposure to toxins. Recognizable symptoms often encompass fatigue, shortness of breath, leg swelling, and irregular heartbeat. Identification of DCM in its early stages is crucial for effectively managing the condition and preventing potential complications. Diagnostic measures typically involve a combination of medical history assessments, physical examinations, and advanced cardiac imaging techniques. Treatment strategies for DCM are multifaceted and may involve medications to enhance heart function, mitigate symptoms, and manage underlying causes.
Title : Novel ways of cardiovascular risk assessment
Syed Raza, Awali Hospital, Bahrain
Title : Preventing sports-related cardiac arrest: Coronary artery calcium scoring stratifies the benefit of low-dose aspirin use for risk reduction
Arthur J Siegel, Massachusetts General Hospital, United States
Title : Empathy and precision: Revolutionizing communication between cardiologists and patients
Iris Panagiota Efthymiou, University of Greenwich, United Kingdom
Title : Ex-situ organ perfusion and cardiac performance improvement
Y J H J Taverne, Erasmus University Medical Center, Netherlands
Title : Subclinical atherosclerosis: Association with additional risk factors and somatic diseases
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation
Title : The past, present and future of AI in cardiology
Narendra Kumar, HeartbeatsZ Academy, United Kingdom